Fritextsökning
Artiklar per år
Innehållstyper
-
Uppfinningsrikt företag prisat
Diagenic har utsetts till årets mest innovativa företag av det norska forskningsrådet. Priset är till för att uppmuntra ökad FoU-verksamhet.
-
Dyrare klinstudier knäcker biotech-bolag
Mindre biotech-företag sitter i dag i knipa. Minskade budgetar och dyrare klinstudier riskerar att slå ut även goda ideer. Sentoclone utvecklar en metod för att aktivera immunförsvaret för att bekämpa cancer. Företagets första kliniska studier kostar 12 miljoner kronor.
-
With their hands on the legal levers
It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.
-
El kan lindra Parkinson
Genom att stimulera nerver i ryggmärgen hoppas forskarna kunna minska medicindosen hos Parkinsonpatienter.
-
Danskt forskningsföretag topprankas
Bäst i Europa på forskning och utveckling, anser Frost & Sullivan.
-
Stille ingår nytt globalt avtal
GE Healthcare ska distribuera och marknadsföra Stilles operationsbord i USA och på nya marknader.
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study will try to evaluate this, and one thousand people are to be included.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
A smart company takes care of its best
Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
BREAKING